CVT occurring after adenoviral-vector-based COVID-19 vaccination is usually associated with vaccine-induced immune thrombotic thrombocytopenia and the presence of antibodies against platelet factor 4 (PF4) [42,43], but the platelet counts of our patient were normal across multiple blood tests, and PF4 antibodies were not evaluated. This evidence concerns the gene PF4 and COVID-19.